Delta 9 Cannabis (CVE:NINE) Shares Up 3% – Still a Buy?

Delta 9 Cannabis Inc (CVE:NINEGet Free Report)’s stock price was up 3% during mid-day trading on Tuesday . The company traded as high as C$1.13 and last traded at C$1.03. Approximately 68,728 shares were traded during trading, a decline of 41% from the average daily volume of 117,300 shares. The stock had previously closed at C$1.00.

Delta 9 Cannabis Stock Up 3.0 %

The business has a 50-day moving average of C$1.03 and a 200-day moving average of C$1.03. The company has a debt-to-equity ratio of 33.00, a quick ratio of 2.04 and a current ratio of 4.44. The stock has a market capitalization of C$89.36 million and a price-to-earnings ratio of 19.07.

About Delta 9 Cannabis

(Get Free Report)

Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.

Featured Articles

Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.